Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.
Goldaniga
Maria
M
Unità di Ematologia 1, Dipartimento di Ematologia ed Oncologia, Ospedale Maggiore IRCCS, Milan, Italy.
Guffanti
Andrea
A
Gianelli
Umberto
U
Magni
Michele
M
Lambertenghi Deliliers
Giorgio
G
Baldini
Luca
L
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D033581:Stem Cell Transplantation
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D003561:Cytarabine; D000069283:Rituximab; D003907:Dexamethasone; D002945:Cisplatin